Insulin deficiency decreases tissue protein synthesis, albumin mRNA concentration, and albumin synthesis in rats. In contrast, insulin deficiency does not change, or, paradoxically, increases estimates of whole body protein synthesis in humans.
Introduction
Insulin exposure to rat tissues both in vitro and in vivo decreases in vitro estimates of proteolysis and stimulates in vitro estimates of protein synthesis (1) (2) (3) (4) (5) (6) (7) (8) (9) . In humans, insulin infusion, in the absence of an exogenous source of amino acids, decreases the plasma concentrations of most essential amino acids (10) and whole body proteolysis (as assessed by decreased rates of leucine appearance) (11, 12), but does not increase whole-body protein synthesis (as reflected by decreased rates of nonoxidative leucine disposal) (1 1, 12) . During a combined insulin and amino acid infusion, measures of proteolysis are similarly suppressed, whereas the estimates ofprotein synthesis are sustained or slightly increased, depending on the experimental conditions and/or the isotope model employed (13) (14) (15) . In addition, studies employing forearm perfusion (16) and/or muscle biopsy techniques (17, 18) in humans support the efficacy of insulin in suppressing rates of proteolysis, but have failed to demonstrate a stimulatory effect of insulin on muscle protein synthesis.
During insulin withdrawal in type 1 diabetic subjects, rates of whole-body proteolysis are increased (17, (19) (20) (21) (22) , an effect consistent with an inhibitory action of insulin on protein breakdown. However, in contrast to in vitro and in vivo results in rats (1) (2) (3) (4) (5) (6) (7) (8) (9) , insulin withdrawal in humans results in either no change (20, 21) or, paradoxically, in an increase in the nonoxidative leucine disposal (17, 19, 22) .
Taken together, these data support a consistent effect of insulin on protein breakdown but the effects of insulin on protein synthesis remain controversial. This lack of agreement on the effects of insulin on protein synthesis could be the result of problems inherent in the assumptions of the isotope model used to estimate protein synthesis (e.g., CO2 fractional recovery is constant) and/or due to the fact that estimates ofwhole-body protein synthesis in humans reflect the net result ofdifferential effects of insulin (some stimulatory and some inhibitory) on the synthesis of specific proteins. This latter hypothesis is supported by the results of a number of studies demonstrating a selective effect of insulin on the cell concentrations of specific mRNAs and, consequently, on the synthetic rates ofindividual proteins (23) (24) (25) . In particular, albumin mRNA concentration and albumin synthesis are increased by insulin, both in vivo in rats (26, 27) and in liver cell cultures (25, 28) , whereas no effect of insulin on fibrinogen synthesis has been observed (29, 30) . Thus, the metabolic stress induced by insulin deficiency could result in an increase in the synthetic rates of acute phase reactant proteins that could obscure the concomitant decrease in the synthesis of other insulin-sensitive proteins.
Therefore, the present study was designed to determine the effects of insulin withdrawal on CO2 fixation and on the estimated rates of protein synthesis using simultaneous infusions of NaH'3C03 and ['4C]leucine infusion, respectively, and to determine the fractional protein synthetic rate of albumin and of the acute reactant phase protein fibrinogen.
Methods
Materials. Purity and sterility of L-[l-'4C]leucine (> 55 mCi/mmol, thrombin, and CaCl2 were obtained from Sigma Chemical Co., St.
Louis, MO.
Protocol. Six type 1 diabetic women without complications or other cardiovascular or renal disease were studied twice in the presence or in the absence of an insulin infusion. All subjects had a normal physical examination, chemistry group, urinalysis, and hematology group before being admitted to the study. Other clinical features ofthe patients are summarized in Table I . No subject had a C-peptide response > 0.04 nM after a 1-mg intravenous glucagon injection. Absence of endogenous insulin secretion was confirmed by lack of increase in the C-peptide concentration during the hyperglycemic component of this study (see Results).
For the 4 d before the first study, all subjects consumed a known caloric diet in the Clinical Research Center (CRC) ofthe Mayo Clinic. The diet provided 30-35 cal -kg-' * d-l, 50-60% carbohydrate, 10-15% protein, and the remainder as fat. At least 72 h before the first study all intermediate or long-acting insulin was stopped and the subjects were treated with four daily subcutaneous injections of regular insulin.
On the evening of the admission to the CRC, the patients received their last subcutaneous injection of regular insulin at 16:30 h and consumed their standard supper meal at 17:00 h. At 20:00 h, two intravenous catheters were placed in a vein of both forearms, one for the purpose of insulin and/or glucose infusion and the other for frequent plasma glucose determinations (20-30-min intervals).
The insulin infusion was adjusted to maintain the subjects at near euglycemia (au 5.5 mM) and was continued until the end of study 1 (13:00 h). At 05:00 h on the day of study an intravenous catheter was positioned in retrograde fashion in a dorsal hand vein and the hand placed in a warming box to obtain arterialized venous blood (33 Upon completion of study 1 (300 min) the isotope and insulin infusions were discontinued, and the subjects were permitted to ambulate freely in the CRC. They consumed their lunch meal but received no insulin. They were subsequently fasted but permitted to drink water ad libitum until the completion of study 2. The subjects were followed carefully; fluid balance, plasma glucose, and urinary ketone bodies were measured every 2-4 h. Upon appearance of urinary ketones, arterialized venous blood gases were determined and repeated every 3-4 h. When the plasma bicarbonate reached the concentration of 20 mM ( 12±2 h after insulin withdrawal), study 2 was initiated and (40) were determined as previously described. Plasma catecholamines were measured through the Mayo Regional Laboratory by HPLC (41) . Arterialized venous measurements of pH, Pco2, Po2 and bicarbonate were determined by the Mayo Clinic Respiratory Laboratory using an IL-1310 gas analyzer (Instrumentation Laboratory, Inc., Lexington, MA). Blood hematocrit, plasma albumin, and fibrinogen concentrations were measured through the Mayo Clinic General Chemistry and Hematology Laboratories.
Plasma concentration and sp act of KIC and leucine were determined by HPLC as previously described (42) . Plasma amino acid concentrations were measured by ion exchange chromatography (model 7300, amino acid analyzer; Beckman Instruments, Inc., Palo Alto, CA) (32) . Expired rates of '4CO2 were measured by aspirating 2-min collections ofexpired air through an ethanolamine solution (43) . In addition, the sp act of breath 14C02 was determined at each breath sampling time by aspirating expired air through hydroxyde of hyamine (43) . The 14C radioactivity in KIC, leucine, and CO2 was determined with a model LS5000 TD series liquid scintillation counter (Beckman Instruments, Inc.).
The sp act of leucine in plasma fibrinogen was determined as previously described (42) with the exception that peak areas were used. Plasma albumin was isolated using the following procedure. Plasma globulins were crudely removed from 2 ml of defibrinated plasma by adding 1.33 ml of a supersaturated ammonium sulfate solution. The supernatant was subsequently extracted with 2 ml of absolute ethanol (44) . The ethanol fraction was dried and subsequently analyzed by SDS-PAGE using an overloaded gel and yielded a single large band which comigrated with fraction V albumin. The purified plasma albumin fraction was subsequently hydrolyzed (at 1 10°C for 72 h), and the sp act of leucine contained in the albumin fraction was analyzed utilizing procedures identical to those employed for the fibrinogen analysis.
13Co2 enrichments and NaH'3CO3 infusion rates were determined using an automated isotope ratio mass spectrometer as previously de- scribed (45 Calculations. The actual rates of NaH'3C02 infusion were determined as the product of the infusate stable isotope concentration, isotope enrichment, and the pump infusion rate (45) . Total CO2 production (mmol * kg-' -min-') was calculated by dividing expired '4C02 (dpm * kg-' -min-') by the '4CO2 sp act (dpm * mmol-') as previously described (43) . The expired rate of '3CO2 was calculated by multiplying the '3CO2 enrichment by the total rate of expired CO2
(mmol * kg-' * min-'). "3Co2 recovery in breath was calculated by dividing the rate of '3CO2 expired by the NaH"3CO2 infusion rate. Rates ofradiolabeled isotope administration were determined by multiplying the dpm -ml-' ofinfusate by the infusion rate ofthe pump (ml * min-').
Estimates of whole body leucine metabolism were made at substrate and isotopic steady state between 200 and 300 min using the reciprocal pool model as previously described (31) . The rate of leucine oxidation was calculated as previously described (31) using the ['4C]KIC sp act and '4CO2 expired rate after correcting for the "CO2 recovery determined simultaneously.
The fractional synthetic rate of albumin and fibrinogen was calculated by dividing the rise of leucine sp act measured hourly (dpm mmol-' h-') from 3-5 h by the mean plasma SA of KIC (dpm * mmol-') during the same period of time (31) . The daily fractional synthetic rate was extrapolated by multiplying the previous result by 24. The measurement of the fractional synthetic rate assumes that (a) labeled and unlabeled leucine are utilized identically in protein synthesis; (b) once synthesized the protein is released into the circulation without being degraded or stored (46, 47) ; (c) leucine SA in plasma protein increases linearly during the time course ofthe isotope infusion (see Fig. 3 (48) ; (e) over the course of the isotope infusion no significant recycling of labeled nascent proteins occurs from the peripheral extravascular space to the intravascular space (49) . By using radioiodinated albumin it has been estimated that 7-10 d are required for a complete equilibration of labeled albumin between the two pools (50). Therefore, we are able only to estimate the fractional rate ofthe intravascular albumin pool but not that ofthe total albumin pool. Consequently, valid estimates of the half-life of albumin cannot be obtained. In contrast, only 20% oftotal body fibrinogen is located in the extravascular bed (51) . The half-life of plasma fibrinogen was calculated by dividing the natural log of 2 (In2) by the fractional synthetic rate.
Statistics. Data are expressed as mean±SEM. Comparisons have been carried out using the Wilcoxon nonparametric test for paired observations (52) . Values were considered to be significantly different with a P < 0.05. Linearity of label incorporation into plasma albumin and fibrinogen was tested according to the method suggested by Snedecor and Cochran (53) . Model fitting was performed using the general linear procedure of the SAS-STAT package version 6.06 (54) .
Results
Insulin, C-peptide, andglucose. Overnight insulin infusion preceding study 1 resulted in a mean plasma glucose concentration of 5.9±0.2 mM between midnight and 6 a.m. During study 1, insulin was infused at the rate of 0.21±0.02 mU * kg-' min-' and plasma free insulin levels were 37±1 pM, whereas during study 2 plasma free insulin was below limits of the assay (15 pM). Plasma C-peptide concentrations during two studies were superimposable and <0.03 nM. Mean plasma glucose concentration during study 1 was 5.7±0.2 mM, whereas during study 2 it was 16. 1 + mM (P < 0.03).
Bicarbonate andpH. Arterialized venous bicarbonate concentrations decreased 36% by the end ofstudy 2 in comparison to study 1 (300 min; study 1, 25±0.2 mM; study 2, 16+2 mM; P < 0.03); similarly, blood pH decreased from 7.40±0.01 (mean value of study 1) to 7.30±0.03 by the end of study 2 (P <0.03).
Counterregulatory hormones (Fig. 1) . Plasma concentrations of glucagon and cortisol were increased (P < 0.03) during the insulin withdrawal study when compared with the insulin infusion study (P < 0.03); plasma growth hormone concentration was higher during study 2 (Table II) . The total plasma concentration of the acid-neutral amino acids was similar in both studies. The total concentration of the essential amino acids was increased (P < 0.03) during study 2, whereas that of the nonessential amino acids was decreased (P < 0.03) during study 2 when compared with those of study 1. Most of the increase in the plasma concentration of the essential amino acids after insulin withdrawal was due to increases of the branched chain amino acids (BCAA), whose plasma concentration more than doubled (P < 0.03) between studies 1 and 2. Among the nonessential amino acids no significant difference between the two studies was observed for the plasma cysteine and tyrosine concentrations, whereas all the other amino acids measured showed a significant decrease after insulin withdrawal (P < 0.03). Total CO2 production and '3C02 recovery in breath (Table  III) . Total CO2 production increased by 13% during study 2 in comparison with study 1; this difference, however, was not statistically significant. The recovery of "CO2 from infused NaH'3CO3 in expired air during the last 100 min of study 1 was 85±3%, a value not statistically different from that observed during the same time interval of study 2 (84±3%).
Leucine kinetics (Tables II, III, and Fig. 2 ). Plasma leucine (Table II) and KIC (Table III) concentrations were stable throughout each of the two studies, although plasma leucine and KIC concentrations were 100 and 20% higher, respectively, during study 2 when compared with those of study 1 (P < 0.03).
The infusion rate of radioactive leucine was 9.2±0.7 during study 1, and 11.4+0.7. 103 dpm * Kg-' . min-' during study 2. Both plasma concentration and plasma ['4C]KIC sp act were at near steady over the last 100 min ofboth studies 1 and 2 (Table  III) .
Leucine rate of appearance was increased (P < 0.03) by 35% (1.85±0.12 vs. 1.37±0.12 ,umol-kg-'-min-') during insulin withdrawal when compared with the insulin infusion study (Fig. 2) . Concomitantly the rate of leucine oxidation was increased (P < 0.03) 100% during insulin withdrawal (0.54±0.08 vs. 0.24±0.03,Mmol -kg-' min-'); whereas the rate of nonoxidative leucine disposal was not significantly higher (P = 0.21), during insulin withdrawal (study 1, 1.12±0.11 vs. study 2, 1.31±0.08 umol -kg-' min-').
Plasma concentrations andfractional synthetic rates of albumin andfibrinogen (Table IV, Fig. 3 ). Plasma albumin concentration during the two studies did not change (4.1+0.2 vs. dpm* nmol-' -min') the baseline contribution to these results would be negligible, indicating that the albumin and fibrinogen fractional synthetic rates ofthe two studies can be compared in a valid fashion. The estimated daily fractional albumin synthetic rate during the insulin infusion study was 9.9±1.2% and decreased (P <0.03) by 29% during the insulin withdrawal study (7.0±2.6%).
The estimated daily fractional fibrinogen synthetic rate during the insulin infusion study was 22±2% and increased (P < 0.03) to 33±5% during the insulin withdrawal study, an increase ofnearly 50%. The calculated half-life ofplasma fibrinogen during the insulin infusion study was 3.1±0.4 d and decreased (P < 0.03) to 2.1±0.3 d after insulin withdrawal. 
Discussion
The present study demonstrates that short-term insulin deficiency in type 1 diabetic subjects leads to an increase in the rates of whole body proteolysis and of leucine oxidation, but has no effect on the estimated rate of whole body protein synthesis. This latter result would suggest that insulin does not regulate protein synthesis in humans. However, during insulin deficiency, we detected a significant decrease in the fractional synthetic rate of albumin and a concomitant significant increase in that of fibrinogen. These data indicate a differential effect of insulin deficiency on the fractional synthetic rate of two hepatically synthesized plasma proteins. Thus, the observed absence ofchanges in the estimated whole body protein synthetic rate during insulin deficiency was most likely due to a concomitant increase in the synthesis of some body proteins All slopes of plasma albumin and fibrinogen sp act are statistically significant (P < 0.01).
and to a concomitant and offsetting decrease in the synthetic rate of others. In the present study, as has already been observed by others (18, 20, 21) insulin deficiency resulted in an increase in the plasma concentration of the essential amino acids, primarily the BCAA, attributable to the increased rate of whole body proteolysis observed after insulin withdrawal (; 35%), because estimates of whole body protein synthesis did not change. In contrast to the essential amino acids, the plasma concentration of the nonessential amino acids significantly decreased after insulin withdrawal. Because proteolysis was increased, this reduction in the plasma concentration ofthe nonessential amino acids was most likely due to decreased de novo synthesis and/or increased rates of utilization. The increase in the rate ofutilization of the nonessential amino acids is consistent with increased gluconeogenis, known to occur with insulin deficiency (55, 56) .
During insulin deficiency, the rate ofleucine oxidation was increased more than 100%. This observation is consistent with other reports both in vitro (57) and in vivo (58) that increased concentration of leucine and KIC are associated with an activation of the branched chain a-ketoacid dehydrogenase and with increased rates of oxidation of the carbon skeleton of leucine. Extrapolating the increase in leucine oxidation to other amino acids, these data are consistent with the nitrogen wasting known to occur in poorly controlled diabetics (59) and the increased use of amino acids as an energy source as has been shown in iatrogenically-induced protein catabolism associated with the administration of glucocorticosteroids in humans (60) .
Leucine oxidation is calculated by dividing the rate of labeled C02 expired in breath by the precursor pool sp act (31) . Because part of the labeled CO2 generated from the oxidation ofleucine is retained in the body during the course ofthe study, the rate of expired labeled CO2 must be corrected for such fixation and has been estimated in normal subjects to be 19% (61). In previous studies in which the effects of insulin withdrawal were compared with those of insulin replacement (17, (19) (20) (21) (22) ) the fractional CO2 recovery was not determined and was assumed to be constant. During an infusion of ['3C]bicarbonate, recovery of tracer in breath increased linearly with CO2 production (62; Horber, F., and M. Haymond, unpublished data), suggesting that increased CO2 production, as might occur in ketoacidosis after insulin withdrawal, could result in an increase in the fractional CO2 recovery. Failure to account for this could lead to overestimate leucine oxidation and to underestimate protein synthesis. However, because CO2 production was slightly but not significantly increased in the present study this cannot be a factor. Conversely, CO2 recovery might have been decreased during insulin deficiency as a result of a greater fractional fixation of labeled CO2 due to increased gluconeogenesis during insulin deficiency (55, 56) . This possibility is indirectly supported by the observation that factors known to suppress gluconeogenesis, such as feeding (62) , decrease CO2 recovery, whereas gluconeogenic stimuli, such as fasting (62) or steroid administration (Horber, F., B. Beaufrere, and M. Haymond, unpublished data), increase it.
In the present study, the fractional CO2 recovery did not significantly change under the two experimental conditions. The absence of significant changes in the fraction of CO2 fixed between the insulin replacement and withdrawal protocols suggest that errors in CO2 fixation could not be used to explain the failure of previous studies ( 17, (19) (20) (21) (22) to observe a decrease in whole body protein synthesis during insulin deficiency or withdrawal.
Insulin deficiency induced both in vitro and in vivo significantly decreases in vitro measures of protein synthesis and, conversely, insulin administration stimulates it (1, 2, 4-9, 63). Insulin regulates protein synthesis at both the translational and transcriptional levels. At the translational level insulin stimulates peptide chain initiation factors (1, 9) and increases the number of ribosomes as evidenced by increased ribosomal RNA (4, 6) . At the transcriptional level insulin acts by either increasing (23, 25) or decreasing (23, 24) the cell content of specific mRNAs. These latter observations indicate that insulin can selectively stimulate the synthesis of some proteins and inhibit that of others (23). In humans, measurements ofwhole body protein synthesis reflect the sum of the effects of insulin on the synthetic rates of all body proteins; therefore, during insulin deficiency a reduction in the synthesis ofsome proteins which anabolically respond to insulin could be obscured by a concomitant increase in the synthesis of other proteins whose production may be inhibited by insulin or stimulated by other factors.
The stimulatory effects of insulin on albumin synthesis have been clearly demonstrated both in liver cell cultures (25, 28) and in vivo in rats (26, 27) . In diabetic rats, insulin deficiency significantly decreased the intracellular concentration ofalbumin mRNA with a resultant decrease ofalbumin synthesis (27). Subsequent insulin administration increased both albumin mRNA concentration and albumin synthesis, which were completely normalized after 3 d of treatment (27). In contrast, fibrinogen synthesis in vitro is not affected by insulin administration (29, 30) , whereas it is increased by other hormones such as corticosteroids and triiodothyronine (29) and by interleukin-6 (64), a monokine that appears to play a key role in determining the response to stress of acute phase reactant proteins (64) .
In our diabetic subjects during insulin replacement the calculated daily fractional synthetic rate ofalbumin (10±1 %) and that of fibrinogen (22±2%) are comparable with those recently reported in normal subjects during rest (65) and to those recently obtained in normal subjects in our laboratory (unpublished data). Also the half-life of fibrinogen (3.1±0.4 d) in the insulin-treated diabetic subjects was not different from that previously calculated in normal subjects (3-4 d) using other techniques (66) (67) (68) (69) . Short-term insulin withdrawal resulted in a 29% decrease in the albumin synthetic rate and in a concomitant 50% increase in the fibrinogen synthetic rate. Since between the two studies and in the time frame of the same study no change occurred in the hematocrit or in the concentration of either plasma albumin or fibrinogen, these changes in the calculated fractional synthetic rates are indicative of the relative changes in their synthetic rates.
In the present study we demonstrate, for the first time, that in humans reciprocal changes in the synthetic rate ofthese two hepatic proteins occurred under conditions of insulin deficiency. However, we cannot exclude that factors other than insulin deficiency per se might have been responsible for the results observed. Insulin withdrawal was associated with a significant increase in the plasma concentration ofcortisol, glucagon, FFA, ketone bodies, and essential amino acids which have been reported to affect leucine and protein metabolism (13, 15, 56, 58, (70) (71) (72) (73) (74) (75) . However, in absence of other hormonal inter-actions in vitro, insulin deficiency decreased the rate of albumin gene transcription and, conversely, insulin replacement increased it (28) . In contrast, no effect of insulin on fibrinogen synthesis has been reported in vitro (29, 30) , suggesting that the increase in fibrinogen synthetic rate observed in the present study was due to factors other than insulin deficiency. Other hormones such as cortisol and triiodothyronine are potent in vitro stimulators of fibrinogen synthesis (29) , as well as interleukin-6 (64). Thus, the increase in the fractional synthetic rate of fibrinogen is consistent with the higher plasma cortisol concentration observed during insulin deficiency.
If our finding for albumin and fibrinogen synthesis can be extrapolated, populations ofproteins throughout the body may be stimulated by insulin, whereas others may be unaffected or inhibited by insulin. This alone could account for the failure to demonstrate significant changes in whole body estimates of protein synthesis during insulin deficiency. Other than in rat liver (23), a selective effect of insulin on protein synthesis has also been reported in rat cardiac muscle, where insulin deficiency was associated with a decreased transcription of 11 mRNA species and with a concomitant increased transcription of eight other specific mRNAs (76) . Studies in humans using organ balance (16) and muscle biopsies (17, 18 ) have failed to demonstrate an effect ofinsulin on whole muscle tissue protein synthesis. Therefore, future studies in humans must address the effect ofinsulin on the synthesis of specific muscle proteins.
